A meta-analysis of the outcome of endovascular and noninvasive therapies in the treatment of intermittent claudication

Journal of Vascular Surgery

Volumn 54, Issue 5, 2011, Pages 1511-1521

  Ahimastos, Anna A ^a   Pappas, Elise P ^b   Buttner, Petra G ^b   Walker, Philip J ^c   Kingwell, Bronwyn A ^a   Golledge, Jonathan ^b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; ANTIHYPERTENSIVE AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGIOPLASTY; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; EFFECT SIZE; ENDOVASCULAR SURGERY; FOLLOW UP; GROIN HEMATOMA; HEMATOMA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFORMATION RETRIEVAL; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; META ANALYSIS; NON INVASIVE PROCEDURE; NUTRITIONAL COUNSELING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORY DYSFUNCTION; SMOKING CESSATION; STENT; SUPERVISED EXERCISE; THERAPY; TREADMILL EXERCISE; TREATMENT INDICATION; TREATMENT OUTCOME; WALKING;

ANKLE BRACHIAL INDEX; CARDIOVASCULAR AGENTS; ENDOVASCULAR PROCEDURES; EVIDENCE-BASED MEDICINE; EXERCISE TEST; EXERCISE THERAPY; EXERCISE TOLERANCE; HUMANS; INTERMITTENT CLAUDICATION; PERIPHERAL ARTERIAL DISEASE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME; WALKING;

EID: 80054860787     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.06.106     Document Type: Article

References (33)

1. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-24. (Pubitemid 33015522)
2. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004;110: 738-43. (Pubitemid 39056275)
3. Rose GA, Blackburn H. Cardiovascular survey methods. Monogr Ser World Health Organ 1968;56:1-188.
4. Regensteiner JG, Hiatt WR, Coll JR, Criqui MH, Treat-Jacobson D, McDermott MM, et al. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Vasc Med 2008;13:15-24. (Pubitemid 351596924)
5. McDermott MM, Liu K, Greenland P, Guralnik JM, Criqui MH, Chan C, et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 2004;292: 453-61. (Pubitemid 38988954)
6. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg 1996;23:104-15. (Pubitemid 26037967)
7. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006;47:1239-312.
8. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-Society Consensus for the Management of peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45 Suppl S:S5-67.
9. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151:W65-94.
10. Oliver LN, Buttner PG, Hobson H, Golledge J. A meta-analysis of randomised controlled trials assessing drug-eluting stents and vascular brachytherapy in the treatment of coronary artery in-stent restenosis. Int J Cardiol 2008;126:216-23. (Pubitemid 351611666)
11. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12. (Pubitemid 26120810)
12. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-4. (Pubitemid 32378696)
13. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45:255-68.
14. Mazari FA, Gulati S, Rahman MN, Lee HL, Mehta TA, McCollum PT, et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Ann Vasc Surg 2010;24:69-79.
15. Whyman MR, Fowkes FG, Kerracher EM, Gillespie IN, Lee AJ, Housley E, et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. Eur J Vasc Endovasc Surg 1996;12:167-72. (Pubitemid 26293573)
16. Creasy TS, McMillan PJ, Fletcher EW, Collin J, Morris PJ. Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. Eur J Vasc Surg 1990;4:135-40. (Pubitemid 20172197)
17. Perkins JM, Collin J, Creasy TS, Fletcher EW, Morris PJ. Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. Eur J Vasc Endovasc Surg 1996;11:409-13. (Pubitemid 26192844)
18. Greenhalgh RM, Belch JJ, Brown LC, Gaines PA, Gao L, Reise JA, et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. Eur J Vasc Endovasc Surg 2008;36:680-8.
19. Gelin J, Jivegård L, Taft C, Karlsson J, Sullivan M, Dahllöf AG, et al. Treatment efficacy of intermittent claudication by surgical intervention, supervised physical exercise training compared to no treatment in unselected randomised patients I: one year results of functional and physiological improvements. Eur J Vasc Endovasc Surg 2001;22: 107-13. (Pubitemid 32737452)
20. Whyman MR, Fowkes FG, Kerracher EM, Gillespie IN, Lee AJ, Housley E, et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. J Vasc Surg 1997;26:551-7. (Pubitemid 27459599)
21. Nylaende M, Abdelnoor M, Stranden E, Morken B, Sandbaek G, Risum Ø, et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT-the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Eur J Vasc Endovasc Surg 2007;33:3-12. (Pubitemid 44856515)
22. Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG. Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training-randomized controlled trial. Radiology 2009;250:586-95.
23. Hobbs SD, Bradbury AW. The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication. J Vasc Surg 2006;44:432-3. (Pubitemid 44142920)
24. Murphy TP, Hirsch AT, Ricotta JJ, Cutlip DE, Mohler E, Regensteiner, DE, et al. The Claudication: Exercise vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. J Vasc Surg 2008;47:1356-63.
25. Currie IC, Wilson YG, Baird RN, Lamont PM. Treatment of intermittent claudication: the impact on quality of life. Eur J Vasc Endovasc Surg 1995;10:356-61.
26. Feinglass J, McCarthy WJ, Slavensky R, Manheim LM, Martin GJ. Functional status and walking ability after lower extremity bypass grafting or angioplasty for intermittent claudication: results from a prospective outcomes study. J Vasc Surg 2000;31:93-103. (Pubitemid 30067306)
27. Taft C, Karlsson J, Gelin J, Jivegård L, Sandström R, Arfvidsson B, et al. Treatment efficacy of intermittent claudication by invasive therapy, supervised physical exercise training compared to no treatment in unselected randomised patients II: one-year results of health-related quality of life. Eur J Vasc Endovasc Surg 2001;22:114-23. (Pubitemid 32737453)
28. Van Rij AM, Packer SGK, Morrison N. A randomized controlled study of percutaneous angioplasty for claudicants with femoro-popliteal disease. J Cadiovsc Surg 1991;32:34.
29. Leicht AS, Crowther RG, Muller R, Golledge J. The effects of including quality of life responses in models to predict walking performance of patients with intermittent claudication. Eur J Vasc Endovasc Surg 2011;41:511-7.
30. Golledge J, Garratt A, Greenhalgh RM, Davies AH. Patient-assessed health outcomes in peripheral arterial disease. Eur J Vasc Endovasc Surg 2000;19:109-10. (Pubitemid 30179529)
31. Patterson RB, Pinto B, Marcus B, Colucci A, Braun T, Roberts M. Value of a supervised exercise program for the therapy of arterial claudication. J Vasc Surg 1997;25:312-8; discussion 318-9.
32. de Vries SO, Visser K, de Vries JA, Wong JB, Donaldson MC, Hunink MG. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy. Radiology 2002;222:25-36. (Pubitemid 34031460)
33. Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial. J Vasc Surg 2008;48: 1472-80.